MetLife (MET) director acquires 534 shares at $81.93 — Form 4
MetLife, Inc. (MET) non‑management director Carla A. Harris acquired 534 shares of MetLife common stock on 10/01/2025 at a reported price of $81.93 per share.
Rhea-AI Filing Summary
MetLife, Inc. (MET) non‑management director Carla A. Harris acquired 534 shares of MetLife common stock on 10/01/2025 at a reported price of $81.93 per share. After this transaction the reporting person beneficially owned 9,048 shares. The filing states these shares represent part of director retainer fees that were elected to be deferred under the MetLife Deferred Compensation Plan for Non‑Management Directors. The Form 4 was signed by an attorney‑in‑fact on behalf of the reporting person on 10/03/2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 534 shares
Grant/Award
1 txn
Insider
Harris Carla A
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 534 | $81.93 | $44K |
Holdings After Transaction:
Common Stock — 9,048 shares (Direct)
Footnotes (1)
- F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
FAQ
What did MetLife director Carla A. Harris report on Form 4 (MET)?
The Form 4 reports the acquisition of 534 shares on 10/01/2025 at $81.93 per share and beneficial ownership of 9,048 shares after the transaction.
How was the Form 4 signed and when?
The Form 4 was signed by an attorney‑in‑fact, Taylor McInerney Jansen, on behalf of the reporting person on 10/03/2025.
What is the reporting person's relationship to MetLife?
The reporting person, Carla A. Harris, is listed as a Director and the Form is filed by one reporting person.
AI-generated analysis. How Rhea-AI works. Not financial advice.